
(AGENPARL) – SILVER SPRING ven 28 aprile 2023 FDA guidance and regulatory information, specific FDA projects related to monitoring and assessment of MCMs, ongoing FDA work related to medical product assessment in general, and key efforts relevant to MCM monitoring and assessment outside of FDA
Fonte/Source: http://www.fda.gov/emergency-preparedness-and-response/mcm-issues/medical-countermeasure-monitoring-and-assessment